Literature DB >> 2283525

Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia.

T Q Nijst1, R A Wevers, H C Schoonderwaldt, O R Hommes, A F de Haan.   

Abstract

Vitamin B12 and folate concentrations were measured in serum and cerebrospinal fluid (CSF) in 293 neurological patients. Serum and CSF vitamin B12 concentrations showed a positive correlation. In individual patients CSF B12 concentrations varied considerably for a given serum concentration. The median serum vitamin B12 concentration of the Alzheimer's type dementia group was significantly lower compared with that of a control group. Lower median CSF vitamin B12 concentrations were found in groups of patients with multiple sclerosis and Alzheimer's type dementia. Five patients with heterogeneous clinical pictures had unexplained low serum and CSF B12 concentrations without macrocytosis. Two patients had very high serum B12 and low-normal CSF concentrations which could be explained by a blood-brain barrier transport defect. Serum and CSF folate concentrations did not show significant differences between the various groups.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2283525      PMCID: PMC488275          DOI: 10.1136/jnnp.53.11.951

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Relationship between serum and cerebrospinal fluid folate.

Authors:  E H Reynolds; B B Gallagher; R H Mattson; M Bowers; A L Johnson
Journal:  Nature       Date:  1972-11-17       Impact factor: 49.962

2.  Neurological disease associated with folate deficiency.

Authors:  E H Reynolds; P Rothfeld; J H Pincus
Journal:  Br Med J       Date:  1973-05-19

3.  Vitamin B 12 in the serum and the cerebrospinal fluid.

Authors:  E Schrumpf; E Bjelke
Journal:  Acta Neurol Scand       Date:  1970       Impact factor: 3.209

4.  Psychiatric syndromes due to avitaminosis B 12 with normal blood and marrow.

Authors:  R W Strachan; J G Henderson
Journal:  Q J Med       Date:  1965-07

5.  Vitamin B12 deficiency, demyelination, and multiple sclerosis.

Authors:  E H Reynolds; J C Linnell
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

6.  Results of investigations in 150 demented patients consecutively admitted to a psychiatric hospital.

Authors:  E B Renvoize; R K Gaskell; H M Klar
Journal:  Br J Psychiatry       Date:  1985-08       Impact factor: 9.319

7.  Cobalamin binding and uptake in vitro in the human central nervous system.

Authors:  G S Lazar; R Carmel
Journal:  J Lab Clin Med       Date:  1981-01

8.  OBSERVATIONS ON VITAMIN B12 IN SERUM AND CEREBROSPINAL FLUID IN MULTIPLE SCLEROSIS.

Authors:  W BASIL; J K BROWN; D M MATTHEWS
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

9.  Low serum cobalamin levels in primary degenerative dementia. Do some patients harbor atypical cobalamin deficiency states?

Authors:  D S Karnaze; R Carmel
Journal:  Arch Intern Med       Date:  1987-03

10.  Pernicious anemia in the demented patient without anemia or macrocytosis. A case for early recognition.

Authors:  J S Gross; N T Weintraub; R R Neufeld; L S Libow
Journal:  J Am Geriatr Soc       Date:  1986-08       Impact factor: 5.562

View more
  12 in total

Review 1.  The influence of nutritional factors on the prognosis of multiple sclerosis.

Authors:  Gloria von Geldern; Ellen M Mowry
Journal:  Nat Rev Neurol       Date:  2012-10-02       Impact factor: 42.937

2.  Folate deficiency in cerebrospinal fluid associated with a defect in folate binding protein in the central nervous system.

Authors:  R A Wevers; S I Hansen; J L van Hellenberg Hubar; J Holm; M Høier-Madsen; P J Jongen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

Review 3.  [Diet and multiple sclerosis].

Authors:  S Schwarz; H Leweling
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

4.  Decreased vitamin B12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after high-dose intravenous methylprednisolone.

Authors:  S T Frequin; R A Wevers; M Braam; F Barkhof; O R Hommes
Journal:  J Neurol       Date:  1993-05       Impact factor: 4.849

5.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

6.  Amnionless (AMN) mutations in Imerslund-Gräsbeck syndrome may be associated with disturbed vitamin B12 transport into the CNS.

Authors:  A S Luder; S M Tanner; A de la Chapelle; J H Walter
Journal:  J Inherit Metab Dis       Date:  2008-01-07       Impact factor: 4.982

Review 7.  The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.

Authors:  T Bottiglieri; K Hyland; E H Reynolds
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

8.  Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.

Authors:  Graham R Campbell; Yevgenya Kraytsberg; Kim J Krishnan; Nobuhiko Ohno; Iryna Ziabreva; Amy Reeve; Bruce D Trapp; Jia Newcombe; Richard Reynolds; Hans Lassmann; Konstantin Khrapko; Doug M Turnbull; Don J Mahad
Journal:  Acta Neuropathol       Date:  2012-06-12       Impact factor: 17.088

9.  Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?

Authors:  Mohamad Reza Najafi; Vahid Shaygannajad; Maryam Mirpourian; Ali Gholamrezaei
Journal:  Int J Prev Med       Date:  2012-04

Review 10.  Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses.

Authors:  Martijn C de Wilde; Bruno Vellas; Elodie Girault; Aysun Cetinyurek Yavuz; John W Sijben
Journal:  Alzheimers Dement (N Y)       Date:  2017-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.